Ondansetron HCL Tablets

Closed Solicitation Posted

Solicitation number
SPE2D2-25-R-0017
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical is procuring Ondansetron HCL Tablets through a national contract solicitation (SPE2D225R0017). The solicitation seeks five different configurations of Ondansetron HCL tablets in 4 mg and 8 mg strengths, available in 30, 100, and 500 count bottles. Offerors must demonstrate FDA current Good Manufacturing Practice (cGMP) compliance, provide detailed product registration information, and meet various federal contracting requirements including trade agreements and small business subcontracting plans. The contract will be awarded using the lowest price technically acceptable (LPTA) evaluation criteria, requiring both comprehensive technical and pricing proposals. Proposals must be submitted through the Defense Logistics Agency Internet Bid Board System (DIBBS) by September 26, 2025 at 3:00 PM EST, with the solicitation having been posted on August 26, 2025.

This procurement does not utilize any set-aside designations and will serve multiple government agencies including the Department of Defense, Veterans Affairs, Indian Health Service, and Bureau of Prisons. The total estimated annual quantity across all participating agencies is 139,933 bottles of the various tablet configurations. The contract structure includes a base year with four option years, providing potential for a five-year contract duration. The solicitation falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals), indicating this opportunity is specifically targeted toward pharmaceutical manufacturers and distributors capable of meeting federal drug supply requirements.

Notice text

Solicitation is attached.

Files

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
Ondansetron HCL Tablets Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
Epinephrine Injector NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity